Background: According to studies on adults, patch testing with aluminium chloride
| INTRODUCTION
Detecting contact allergy to aluminium by patch testing has been practised since 1980, when Clemmensen tested a young girl with standard allergens enclosed in aluminium chambers (Finn Chambers), and found uniformly strong positive reactions to the edges of the chambers, but no reactions where the vehicles and filter paper discs were interposed. 1 The patient had been hyposensitized with aluminium-precipitated grass allergens during the previous 2 years, and presented with itching erythema in both axillae associated with the use of aluminium-containing antiperspirants.
Contact allergy to aluminium was considered to be extremely rare [1] [2] [3] until the 1990s, when an unexpectedly high number of cases (n = 377) was reported following vaccination with an aluminiumadsorbed acellular pertussis vaccine in clinical trials in the greater Gothenburg area in Sweden. 4, 5 All vaccines against diphtheria, tetanus, and pertussis (DTP), hepatitis A and B, human papilloma virus and tickborne encephalitis, as well as some conjugated vaccines against pneumococcal and meningococcal infections, are adsorbed to aluminium salts (mostly hydroxide and phosphate) as adjuvants. Most allergen extracts used for allergen-specific immunotherapy ("hyposensitization") also contain aluminium adjuvants.
Another side-effect of aluminium-adsorbed vaccines and allergen extracts that is associated with aluminium allergy is the formation of long-lasting, intensely itching subcutaneous nodules (granulomas) at the injection site. 1, 4, [6] [7] [8] [9] [10] [11] [12] The nodules appear remarkably late, that is, weeks or months, after vaccination. Pruritus may last for years and be very annoying for both child and family. Exacerbation of the symptoms with swelling of the nodules and intensified itching is seen in about 40% of the children when they have common colds or other ongoing infections. 4 Local hypertrichosis, hyperpigmentation and eczema are common. 4, 13, 14 Vaccination granulomas have been mistaken for tumours. [15] [16] [17] Histopathological examination shows granuloma formations surrounding aluminium crystals. [18] [19] [20] The incidence of itching granulomas after routine vaccination with DTP at 3, 5 and 12 months was 0.63%, as calculated in a prospective study performed in eastern Sweden. If a second aluminium-adsorbed (pneumococcal) vaccine was given concomitantly, the incidence was almost doubled (1.18%).
14 From 2000 to 2014, three separate Swedish studies on vaccineinduced subcutaneous itching granulomas and contact allergy to aluminium were published. They were performed in different settings:
A. In a pertussis vaccine trial 4, 5 B. In clinical practice by the use of spontaneous reports 13 C. In a prospective study in clinical practice 14 Altogether, 601 children with persistent itching vaccination granulomas were patch tested with aluminium in these three studies, as described below in more detail. Sensitization to aluminium was confirmed in 475 (79%) of the children. Fortunately, and in contrast to previous notions, contact allergy to aluminium acquired in childhood seems to weaken or disappear with time, as shown in follow-up studies on participants in the pertussis vaccine trials by Gente Lidholm; of 241 children with known aluminium allergy, only 55 (23%) remained positive when retested 5 to 9 years after the initial patch test. 5, 21 Traditionally in Sweden, contact allergy to aluminium has been diagnosed by patch testing with metallic aluminium (an empty Finn Chamber) and aluminium chloride hexahydrate 2% pet. 22, 23 A higher concentration, namely 10% pet., was used by Netterlid et al in a study including 37 children and young adults who had undergone hyposensitization therapy with aluminium-adsorbed antigen extracts. Eight patients aged 9 to 21 years reacted positively to the 10% preparation, but only three of them also reacted positively to the 2% preparation. 23 Another case of a negative result with aluminium chloride hexahydrate 2% pet. but a positive reaction to the 10% preparation was described by Bruze in a 15-year-old girl with itchy nodules at the injection sites of aluminium-adsorbed pollen extracts. 24 In a study by In contrast, our experience of patch testing children with aluminium in the three studies mentioned above (A-C) was that very high proportions (74%, 86%, and 85%, respectively) not only reacted positively, but often also reacted strongly to aluminium chloride hexahydrate 2% pet. 4, 5, 13, 14 This is consistent with a Danish study by Salik et al, in which 39 of 42 children with vaccine-induced persistent pruritic subcutaneous nodules aged 3 months to 6 years reacted positively to aluminium chloride hexahydrate 2% pet. 26 In a recent French study by Goiset on the prevalence of contact sensitization to aluminium in a paediatric population, 10 children (mean age 3.7 years) with a history of vaccine-induced itching subcutaneous nodules were patch tested with aluminium chloride hexahydrate 2% pet.; all of them reacted positively to this preparation. 27 The aims of this survey were to review three Swedish studies on patch testing children with aluminium chloride hexahydrate 2% pet.
published previously, and to discuss whether this concentration is sufficient and appropriate for detecting delayed hypersensitivity to alu- A positive test result, that is, at least a + reaction to at least one of the testing agents, was found in 377 children aged 1.6 to 15 years (median 6.6 years) (76%). The outcomes of the tests in relation to age are shown in Table 1 . Positive results were associated with young age Table 2) . One of the children with a +++ reaction to aluminium chloride hexahydrate 2% pet., a 3-year-old girl who had experienced itching subcutaneous nodules induced by the study vaccine for half of her life, is shown in Figure 1 .
Clinical presentations of contact allergy to aluminium were reported for several children. Four of them are described here:
Case 1 ( Figure 2 ): This was a 13-year-old girl with persisting itching granulomas at the injection site of three doses of the study vaccine given at 6 to 7 years of age. Patch testing at 11 years gave a + ++ positive reaction to aluminium chloride hexahydrate 2% pet., and a + positive reaction to an empty Finn Chamber. When the patient began using deodorants as a teenager, she experienced vast, intensely itching dermatitis in both axillae that prevented her from using any effective antiperspirants. A new patch test performed at 15 years of age yielded a ++ reaction to her own aluminium-containing deodorant, but no reaction to colophonium, Myroxylon pereirae, or fragrance mix.
Case 2 ( Figure 3 ): This was a 6-year-old boy with persistent itching granulomas at the injection sites of the study vaccine given at 1 to 2 years of age. The day after he used his father's aluminiumcontaining deodorant, itching dermatitis was seen in both axillae. His patch test gave a +++ reaction to aluminium chloride hexahydrate 2%
pet., and a + reaction to an empty Finn Chamber. T A B L E 
| Summary of studies A-C: Clinical aspects
Altogether, 452 children from the three studies had positive reactions with documented strengths to aluminium chloride hexahydrate 2% pet. The relationship between age and strength of reaction is shown in Table 3 . The strongest reactions were seen in the youngest children. As many as 65% of those aged 1 to 2 years had an extreme positive (+++) reaction. The frequency diminished to 22% at 7 years. From 8 years onwards, the frequency of extreme reactions was very low. Table 4) .
| DISCUSSION
In the studies by Netterlid, Bruze, and Siemund, [23] [24] [25] altogether 24 patients who were tested with both concentrations of aluminium chloride hexahydrate pet. reacted positively to the 10% preparation, but only seven of them also reacted positively to the weaker 2% preparation. Therefore, aluminium chloride hexahydrate 10% pet. was recommended for the detection of aluminium allergy by these authors and also by de Groot. 28 On the other hand, there were no small children in these studies; their median ages were >14 years (Netterlid), 15 years (Bruze), and 48 years (Siemund), respectively.
T A B L E 3 Relationship between age and strength of reaction to aluminium chloride hexahydrate 2% pet. in 452 children with vaccine-induced aluminium allergy in three Swedish studies (A, vaccine trial; B, spontaneous reports; C, prospective study) We agree with the above authors that the 10% preparation seems to be adequate for patch testing older children and adults. With this knowledge, it is possible that at least some of the 31 children with doubtful reactions (?+) to aluminium chloride hexahydrate 2% pet. in our vaccine trial (study A above) would have reacted positively if they had been tested with the stronger preparation. Only three children in our studies (aged 2-4 years) were tested with both 2% and 10% aluminium chloride hexahydrate pet. The result-one of them reacted only to the stronger preparation, whereas the other two had positive reactions to both-is evidently not conclusive.
On the basis of the results from our three studies, aluminium chloride hexahydrate 2% pet. is sufficient to trace contact allergy to aluminium in small children. In the vaccine trial, 368 of 377 of the children with verified aluminium allergy reacted positively to this concentration (98%), 62 of 69 among the spontaneously reported children (97%), and 29 of 29 in the prospective study in clinical practice (100%). This is in accordance with the Danish and French studies mentioned in the introduction, in which 93% to 100% reacted positively to aluminium chloride hexahydrate 2% pet. 26, 27 It is also obvious that the majority of children reacted very strongly to aluminium chloride hexahydrate 2% pet. (Tables 3 and 4 and Figures 1, 5 and 6 ). Altogether 69%, 79% and 86%, respectively, of the children in studies A, B and C who reacted positively to this preparation had ++ or +++ reactions. The differences may be explained by age-the younger the children, the stronger the reactions-and possibly also by the intensity of symptoms of the itching granulomas. In the vaccine trials (study A), there was a wide age range, and the intensity and duration of the itching granulomas varied from moderate itching for 6 to 12 months to intense itching for years and a total duration of symptoms for up to 10 years. Almost all spontaneously reported children (study B) had intense and longlasting symptoms, but also a wide age range. The prospective cohort study (study C) comprised only small children with a median age of 2.6 years at the time of testing, but varying symptoms, from mild and short (months) to intense and long-lasting (years).
The reactions were also often seen rapidly after application of the tests. Several children already had such strong reactions on D1 that the test material had to be removed immediately ( Figures 1, 5 and 6 ).
Only a few were negative on D3 and required a second reading. The test reactions could take a long time to resolve, even when treated with local steroids. Some children later experienced a small patch of itching dermatitis in the former test area on the back during an acute infection along with an exacerbation of the itching granuloma on the thigh or upper arm. In others, the itching and swelling of the nodules on the former injection site flared during the patch test, suggesting that systemic allergy had developed. Our experience of cases such as these was one of the reasons why we considered it unethical to use the 10% preparation in the retest study on the long-term prognosis of aluminium allergy, in which children from the vaccine trial were tested a second time.
5,21
The role of metallic aluminium (eg, an empty Finn Chamber) in patch testing for aluminium allergy has been discussed and questioned lately. 21, 22 In our three studies, the diagnosis would have been missed in 10 of 601 cases if we had tested only with the aluminium salt. This is consistent with our earlier conclusion that metallic aluminium is of very little benefit in patch testing for aluminium contact allergy. 21 In summary, we think that aluminium chloride hexahydrate 2% pet. is sufficient for detection of contact allergy to aluminium in small children, and recommend that the stronger 10% preparation should not be used, because of the risk of unwanted strong allergic reactions to the test. Already the 2% preparation can cause strong or extreme positive reactions soon after application, and parents should be advised to check the test area from the first day.
The age at which aluminium chloride hexahydrate 10% pet. should be used instead of 2% is a matter for discussion, and needs further study. According to our findings, we suggest that this concentration
should not be used routinely before the age of 7 to 8 years, when extremely strong reactions were scarce, in order not to risk intense gives a negative result, a test with a 10% preparation should be considered.
